Which antibiotics are safe to use during in vitro fertilization (IVF) treatment, particularly before embryo transfer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Antibiotics Safe During IVF Treatment

Penicillins (amoxicillin, amoxicillin-clavulanate, piperacillin-tazobactam) and cephalosporins (ceftazidime, ceftriaxone, cefixime) are the safest antibiotics during IVF treatment, with azithromycin and erythromycin as acceptable alternatives when needed.

First-Line Safe Options

The safest antibiotics throughout IVF cycles, including before embryo transfer, are:

  • Penicillins: Amoxicillin and amoxicillin-clavulanate are considered compatible throughout all phases of reproductive treatment 1
  • Cephalosporins: Ceftazidime, ceftriaxone, and cefixime show no evidence of fetal harm and are safe options 1
  • Macrolides: Erythromycin is probably safe, though erythromycin estolate should be avoided due to potential maternal hepatotoxicity 1
  • Azithromycin: Possibly safe and commonly used in reproductive medicine settings 1

Antibiotics to Avoid or Use with Caution

Tetracyclines (doxycycline): Should be avoided during the second and third trimesters if pregnancy occurs, as they cause tooth discoloration and bone growth suppression 1. However, doxycycline may be used cautiously in early IVF phases before pregnancy is established 2, 3.

Fluoroquinolones (ciprofloxacin, levofloxacin): While used in pregnancy for specific severe infections, they are not first-line choices during IVF treatment 1.

Aminoglycosides (gentamicin, tobramycin): Should be avoided if possible due to theoretical risk of eighth cranial nerve damage and nephrotoxicity, though this is primarily a concern during established pregnancy 1.

Metronidazole: Possibly safe but should only be used if safer alternatives are unavailable 1.

Evidence on Prophylactic Antibiotics During IVF

The evidence for routine prophylactic antibiotics at embryo transfer is weak. A Cochrane review found that amoxicillin-clavulanate reduced genital tract colonization but did not improve clinical pregnancy rates or live birth rates 4, 5. The most recent evidence suggests:

  • Prophylactic azithromycin at baseline does not significantly alter vaginal bacterial communities or pregnancy outcomes 6
  • Routine antibiotic prophylaxis at embryo transfer is not recommended based on current evidence 7

Special Considerations for Chronic Endometritis

If chronic endometritis is diagnosed (CD138+ plasmacytes ≥5 per 10 high-power fields), longer-term antibiotic therapy with doxycycline may improve pregnancy outcomes before embryo transfer 3. For low-grade chronic endometritis (CD138+ 1-4), short-term antibiotics appear sufficient 3.

Clinical Algorithm

  1. For routine IVF without infection: No prophylactic antibiotics needed at embryo transfer
  2. For documented infection requiring treatment: Use amoxicillin, amoxicillin-clavulanate, or cephalosporins as first-line
  3. For chronic endometritis (high-grade): Consider doxycycline course before embryo transfer cycle
  4. If macrolide needed: Use azithromycin or erythromycin (not estolate form)
  5. Avoid: Tetracyclines after pregnancy confirmed, aminoglycosides, and fluoroquinolones unless specifically indicated

The key principle is that while certain antibiotics are safe during IVF, routine prophylactic use at embryo transfer lacks evidence of benefit and is not recommended 4, 5, 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.